Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
Compositions for affecting weight loss comprising an opioid antagonist and bupropion

No-Receipt date 2017-03029 - 05/09/2017
No-Filing date 20170402415 - 05/09/2017
No-Granting date 3093739 - 11/12/2017
No-EPO application date 10185782.9 - 21/04/2004
No-EPO granting date 2316456 - 14/06/2017
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 12/2017 - 09/03/2018
Expiration date 22/04/2024
Kind of title Validation of European Patent
Legal status NOT VALID
Priorities US466838 P29/04/2003/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 31/137
A61K 31/485
A61K 45/06
A61P 3/04

Related Documents

Related Titles
TypeMaster titleRelated title
[SPC] 20170800060

Owners
CodeFirstnameSurnameAddressTownZIPCountry
795179 OREXIGEN THERAPEUTICS, INC. 3344 NORTH TORREY PINES COURT, SUITE 200LA JOLLA, CA 92037 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
1961878 WEBER, ECKARD
1961879 COWLEY, MICHAEL ALEXANDER

Representatives
CodeFirstnameSurnameAddressTownZip
3190KONSTANTINOSKILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"CHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528

Contact
CodeFirstnameSurnameAddressTownZipCountry
8149KONSTANTINOSKILIMIRISCHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528 GREECE

Owners History

Title Instruments
DateOperationDescreption
5/15/2024 12:00:00 AMΛήξη Προστασίας Τίτλων (79600) 79600

Payments history 20 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015